PrimeVigilance develops and supports development of Benefit-Risk Frameworks for the qualitative assessment of benefit-risk profiles of drugs, and offer services in the selection and execution of appropriate quantitative benefit-risk analysis methods, with hands-on experience in performing Multi-Criteria Decision Analyses (MCDAs) and the conduct of patient and HCP preference studies.
PrimeVigilance’s Human Data Research team provides support in relevant, related evidence generation strategy and designs.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)